Revlon downgrades forecast on weak sales
Revlon has downgraded its sales and profits forecasts after a disappointing performance from two cosmetics lines.
News & Analysis on Cosmetics Innovation
Revlon has downgraded its sales and profits forecasts after a disappointing performance from two cosmetics lines.
CoQ10 focus
The gap between demand and global supply of potent antioxidant coenzyme Q10 (CoQ10) is narrowing, as major manufacturers expand their capacity and new sources enter the marketplace.
Dow Biocides and the Angus Chemical Company are to introduce five regional customer application canters around the world.
A "next generation" of facial wrinkle correction formulas, from Allergan, the makers of Botox, has been given the all-clear by the FDA.